Integrated Filing — IndAS



General information about company

Scrip Code 543318
NSE Symbol CLEAN
MSEI Symbol NOTLISTED
ISIN INE227W01023
Name of company Clean Science and Technology Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 24-04-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Organic Chemicals
Start date and time of board meeting 14-05-2026   12:30:00
End date and time of board meeting 14-05-2026   14:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 30-01-2025
Indicate Company website link for updated RPT policy of the Company https://cleanscience.co.in/wp-content/uploads/2025/04/Policy-on-Related-Party-Transactions-Amended-30012025.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 19,713.00 81,533.50
Other income 16.10 2,750.40
Total income 19,729.10 84,283.90
2 Expenses
(a) Cost of materials consumed 6,957.60 26,935.70
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (509.00) 193.20
(d) Employee benefit expense 109.40 3,814.40
(e) Finance costs 2.60 26.10
(f) Depreciation, depletion and amortisation expense 1,085.30 4,420.30
(f) Other Expenses
1 Other expenses 4,344.20 15,333.10
Total other expenses 4,344.20 15,333.10
Total expenses 11,990.10 50,722.80
3 Total profit before exceptional items and tax 7,739.00 33,561.10
4 Exceptional items 0.00 0.00
5 Total profit before tax 7,739.00 33,561.10
6 Tax expense
7 Current tax 2,281.80 8,837.40
8 Deferred tax (354.90) (398.00)
9 Total tax expenses 1,926.90 8,439.40
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,812.10 25,121.70
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,812.10 25,121.70
17 Other comprehensive income net of taxes 14.40 21.80
18 Total Comprehensive Income for the period 5,826.50 25,143.50
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,062.80 1,062.80
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,63,501.60
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5.47 23.64
Diluted earnings (loss) per share from continuing operations 5.46 23.63
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5.47 23.64
Diluted earnings (loss) per share from continuing and discontinued operations 5.46 23.63
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The Statement has been prepared in accordance with the recognition and measurement principles laid down in India Accounting Standards prescribed under Section 133 of the Companies Act, 2013 read with Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time and the provisions of the Companies Act 2013 and other accounting principles. 2. The Board of Directors in their meeting held on May 14, 2026 have recommended, subject to approval of shareholders, final dividend of Rs. 4 /- per share for the year ended March 31, 2026. 3. The above results have been reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors at its meeting held on May 14, 2026. The standalone financial results for the year ended March 31, 2026 were subject to audit by the Statutory Auditors of the Company and the figures for the quarter ended March 31, 2026 and March 31, 2025, are the balancing figures between the audited figures in respect of the relevant full financial year and unaudited published year to date figures upto the end of the third quarter of the respective financial year. 4. As per Ind AS 108 'Operating Segments', when financial results contains both consolidated and standalone financial results for the parents, segment information needs to be presented only in case of consolidated financial results. Accordingly, segment information has been provided only in consolidated financial results. 5. During the year ended March 31, 2026, 10,040 equity shares of Rs. 1/- each fully paid-up, were allotted upon exercise of the vested stock options pursuant to the Company's Employee Stock Option Scheme, 2021 (ESOP 2021). 6.During the quarter ended March 31, 2026, the Executive Directors voluntarily elected to forgo a substantial portion of their performance bonus entitlement for the financial year 2025-26. Accordingly, the provision for performance bonus recognised in the earlier quarters has been reversed to that extent, resulting in lower employee benefits expense for the quarter ended March 31, 2026 as compared to previous quarter ended December 31, 2025. 7. The standalone results of the Company are available on the Company's website, www.cleanscience.co.in and also on the website of the BSE Limited, www.bseindia.com and National Stock Exchange of India Limited, www.nseindia.com, where the shares of the Company are listed.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 33,960.30
Capital work-in-progress 379.80
Investment property 0.00
Goodwill 0.00
Other intangible assets 25.70
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 81,259.80
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 92.60
Total of other non-current financial assets 92.60
Total non-current financial assets 81,352.40
Deferred tax assets (net) 0.00
Other non-current assets
1 Other non-current assets 7.80
Total of other non-current assets 7.80
Total non-current assets 1,15,726.00
2 Current assets
Inventories 10,194.40
Current financial asset
Current investments 34,277.80
Trade receivables, current 14,947.70
Cash and cash equivalents 1,742.30
Bank balance other than cash and cash equivalents 4.20
Loans, current 0.00
Other current financial assets
Total of other current financial assets 68.10
Total current financial assets 51,040.10
Current tax assets (net)
Other current assets
1 Other current assets 1,434.60
Total of other current assets 1,434.60
Total current assets 62,669.10
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,78,395.10
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,062.80
Other equity 1,63,501.60
Total equity attributable to owners of parent 1,64,564.40
Non controlling interest
Total equity 1,64,564.40
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 293.40
Total of other non-current financial liabilities 293.40
Total non-current financial liabilities 293.40
Provisions, non-current 0.00
Deferred tax liabilities (net) 2,986.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 0.00
Total of other non-current liabilities 0.00
Total non-current liabilities 3,279.40
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 253.70
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 7,172.50
Total Trade payable 7,426.20
Other current financial liabilities
1 Other current financial liabilities 2,042.20
Total of other current financial liabilities 2,042.20
Total current financial liabilities 9,468.40
Other current liabilities 436.30
1 Other current liabilities 436.30
Total of other current liabilities 436.30
Provisions, current 162.30
Current tax liabilities (Net) 484.30
Deferred government grants, Current 0.00
Total current liabilities 10,551.30
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 13,830.70
Total equity and liabilites 1,78,395.10
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of post employment benefit obigations. 19.30 29.20
Total Amount of items that will not be reclassified to profit and loss 19.30 29.20
2 Income tax relating to items that will not be reclassified to profit or loss 4.90 7.40
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 14.40 21.80



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 33,561.10
Adjustments for reconcile profit (loss)
Adjustments for finance costs 26.10
Adjustments for decrease (increase) in inventories 333.80
Adjustments for decrease (increase) in trade receivables, current 3,584.40
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 782.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 193.90
Adjustments for other financial assets, current 35.30
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 38.10
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 163.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 4,420.30
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 82.70
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (1,523.70)
Adjustments for other financial liabilities, non-current 195.00
Adjustments for unrealised foreign exchange losses gains (388.70)
Adjustments for dividend income 6.90
Adjustments for interest income 490.40
Adjustments for share-based payments 54.50
Adjustments for fair value losses (gains) 793.50
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 23.00
Other adjustments to reconcile profit (loss) (1,990.80)
Other adjustments for non-cash items 222.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 6,547.10
Net cash flows from (used in) operations 40,108.20
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 9,120.60
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 30,987.60
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 20,300.10
Other cash receipts from sales of equity or debt instruments of other entities 41,731.00
Other cash payments to acquire equity or debt instruments of other entities 43,851.70
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 61.20
Purchase of property, plant and equipment 2,173.70
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 10.80
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 6.90
Interest received 141.20
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (3.90)
Net cash flows from (used in) investing activities (24,378.30)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 50.30
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 0.00
Dividends paid 6,376.50
Interest paid 25.60
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (6,351.80)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 257.50
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 3.20
Net increase (decrease) in cash and cash equivalents 260.70
Cash and cash equivalents cash flow statement at beginning of period 1,481.60
Cash and cash equivalents cash flow statement at end of period 1,742.30





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Price Waterhouse Chartered Accountants LLP Yes 30-11-2026


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Clean Science and Technology Limited Mr. Ashok Ramnarayan Boob Key Management Personnel (Managing Director) Remuneration 404.40 Approved (69.30) 292.20 20.70 Textual Information(1)
2 Clean Science and Technology Limited Mr. Ashok Ramnarayan Boob Key Management Personnel (Managing Director) Dividend paid 73.40 Approved 73.40 0.00 0.00
3 Clean Science and Technology Limited Mr. Siddhartha Ashok Sikchi Key Management Personnel (Whole-time Director) Remuneration 364.40 Approved 199.30 263.00 280.10 Textual Information(2)
4 Clean Science and Technology Limited Mr. Siddhartha Ashok Sikchi Key Management Personnel (Whole-time Director) Dividend paid 115.00 Approved 115.00 0.00 0.00
5 Clean Science and Technology Limited Mr. Krishnakumar Ramnarayan Boob Key Management Personnel (Whole-time Director) Remuneration 244.40 Approved (41.90) 176.90 12.90
6 Clean Science and Technology Limited Mr. Krishnakumar Ramnarayan Boob Key Management Personnel (Whole-time Director) Dividend paid 4.20 Approved 4.20 0.00 0.00
7 Clean Science and Technology Limited Mr. Parth Ashok Maheshwari Key Management Personnel (Whole-time Director w.e.f. 1st August, 2024) Remuneration 110.00 Approved (46.30) 79.00 0.00
8 Clean Science and Technology Limited Mr. Parth Ashok Maheshwari Key Management Personnel (Whole-time Director) Dividend paid 2.00 Approved 2.00 0.00 0.00
9 Clean Science and Technology Limited Mr. Sanjay Parnerkar Key Management Personnel (Chief Financial Officer) Remuneration 28.30 Approved 28.30 2.70 3.80
10 Clean Science and Technology Limited Ms. Ruchita Vij Key Management Personnel (Company Secretary w.e.f. 1 Aug 2024) Remuneration 16.10 Approved 16.10 3.10 3.20
11 Clean Science and Technology Limited Prof. Ganapati Dadasaheb Yadav Key Management Personnel (Independent Director) Any other transaction Sitting fees 3.50 Approved 3.50 0.00 0.00 Textual Information(3)
12 Clean Science and Technology Limited Prof. Ganapati Dadasaheb Yadav Key Management Personnel (Independent Director) Dividend paid 3.80 Approved 3.80 0.00 0.00 Textual Information(4)
13 Clean Science and Technology Limited Mr. Pradeep Rathi Key Management Personnel (Non-Executive Director) Any other transaction Sitting fees 3.00 Approved 3.00 0.00 0.00
14 Clean Science and Technology Limited Mr. Sanjay Kothari Key Management Personnel (Non-Executive Director) Any other transaction Sitting fees 3.50 Approved 3.50 0.00 0.00
15 Clean Science and Technology Limited Mr. Keval Doshi Key Management Personnel (Independent Director) Any other transaction Sitting fees 4.00 Approved 4.00 0.00 0.00
16 Clean Science and Technology Limited Ms. Madhu Dubhashi Key Management Personnel (Independent Director) Any other transaction Sitting fees 3.00 Approved 3.00 0.00 0.00 Textual Information(5)
17 Clean Science and Technology Limited Ms. Madhu Dubhashi Key Management Personnel (Independent Director) Dividend paid 0.00 Approved 0.00 0.00 0.00 Textual Information(6)
18 Clean Science and Technology Limited Ms. Pallavi Gokhale Key Management Personnel (Independent Director) Any other transaction Sitting fees 1.00 Approved 1.00 0.00 0.00
19 Clean Science and Technology Limited Mr. Raj Kamal Key Management Personnel (Independent Director) Any other transaction Sitting fees 1.00 Approved 1.00 0.00 0.00
20 Clean Science and Technology Limited Ashok Ramnarayan Boob HUF Entities in which KMP are interested Dividend paid 117.10 Approved 117.10 0.00 0.00
21 Clean Science and Technology Limited Ashokkumar Ramkishan Sikchi HUF Entities in which KMP are interested Dividend paid 211.60 Approved 211.60 0.00 0.00
22 Clean Science and Technology Limited Anantroop Financial Advisory Services Private Limited Entities in which KMP are interested Dividend paid 83.40 Approved 83.40 0.00 0.00
23 Clean Science and Technology Limited Krishnakumar Ramnarayan Boob HUF Entities in which KMP are interested Dividend paid 64.60 Approved 64.60 0.00 0.00
24 Clean Science and Technology Limited Mrs. Nandita Sikchi Relative of Key Management Personnel Dividend paid 42.60 Approved 42.60 0.00 0.00
25 Clean Science and Technology Limited Mrs. Asha Ashok Boob Relative of Key Management Personnel Dividend paid 204.00 Approved 204.00 0.00 0.00
26 Clean Science and Technology Limited Mrs. Asha Ashok Sikchi Relative of Key Management Personnel Dividend paid 11.10 Approved 11.10 0.00 0.00
27 Clean Science and Technology Limited Mr. Ashok Sikchi Relative of Key Management Personnel Dividend paid 43.90 Approved 43.90 0.00 0.00
28 Clean Science and Technology Limited Mr. Kunal Ashok Sikchi Relative of Key Management Personnel Dividend paid 48.30 Approved 48.30 0.00 0.00
29 Clean Science and Technology Limited Mrs. Nidhi Mohunta Relative of Key Management Personnel Dividend paid 2.00 Approved 2.00 0.00 0.00
30 Clean Science and Technology Limited Ms. Shardha Krishnakumar Boob Relative of Key Management Personnel Dividend paid 4.40 Approved 4.40 0.00 0.00
31 Clean Science and Technology Limited Mrs. Pooja Vivek Navandar Relative of Key Management Personnel Dividend paid 4.40 Approved 4.40 0.00 0.00
32 Clean Science and Technology Limited Mr. Prasad Krishnakumar Boob Relative of Key Management Personnel Dividend paid 0.00 Approved 0.00 0.00 0.00
33 Clean Science and Technology Limited Mr. Sanjay Parnerkar Key Management Personnel (Chief Financial Officer) Dividend paid 0.00 Approved 0.00 0.00 0.00
34 Clean Science and Technology Limited Mr. Nilima Krishnakumar Boob Relative of Key Management Personnel Dividend paid 134.60 Approved 134.60 0.00 0.00
35 Clean Science and Technology Limited Kunal Ashok Sikchi (As Trustee of AAS Business Trust) Entities in which KMP are interested Dividend paid 0.00 Approved 0.00 0.00 0.00
36 Clean Science and Technology Limited Kunal Ashok Sikchi (As Trustee of ARS Business Trust) Entities in which KMP are interested Dividend paid 0.00 Approved 0.00 0.00 0.00
37 Clean Science and Technology Limited Nilima Krishnakumar Boob (As Trustees of Smt. Alaknanda Boob Business Trust) Entities in which KMP are interested Dividend paid 0.00 Approved 0.00 0.00 0.00
38 Clean Science and Technology Limited Nilima Krishnakumar Boob (As Trustees of Shri Ramnarayan Boob Business Trust) Entities in which KMP are interested Dividend paid 0.00 Approved 0.00 0.00 0.00
39 Clean Science and Technology Limited Asha Ashok Boob (as trustees of AAB Business Trust) Entities in which KMP are interested Dividend paid 0.00 Approved 0.00 0.00 0.00
40 Clean Science and Technology Limited Ashok Ramnarayan Boob (As Trustees of ARB Business Trust) Entities in which KMP are interested Dividend paid 0.00 Approved 0.00 0.00 0.00
41 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Purchase of goods or services 10,000.00 Approved 1,205.30 208.80 52.40
42 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Purchase of fixed assets 2,500.00 Approved 6.50 7.80 0.00
43 Clean Science and Technology Limited Matrix Life Science Private Limited Entities in which KMP are interested Sale of goods or services 500.00 Approved 54.20 40.70 20.40
44 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Sale of goods or services 10,000.00 Approved 523.30 177.70 0.00
45 Clean Science and Technology Limited CSTPL Foundation Entities in which KMP are interested Any other transaction Rent income 5.00 Approved 0.40 0.40 0.80
46 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Any other transaction Rent income 14.00 Approved 5.40 0.00 0.00
47 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Any other transaction Management service income 100.00 Approved 13.00 0.00 0.00
48 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Any other transaction Research and development facility income 19.00 Approved 9.10 0.00 0.00
49 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Any other transaction Management service expenses 100.00 Approved 32.30 0.00 0.00
50 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Investment 5,000.00 Approved 5,000.00 0.00 0.00
51 Clean Science and Technology Limited Mr. Ashok Ramnarayan Boob Key Management Personnel (Managing Director) Any other transaction Unsecured Deposit received 195.00 Approved 195.00 0.00 195.00
52 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Any other transaction Other Equity Contribution 18.70 Approved 18.70 0.00 0.00
53 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Sale of fixed assets 2,500.00 Approved 7.30 0.00 0.00
54 Clean Science and Technology Limited MVS Ventures Private Limited Entities in which KMP are interested Sale of fixed assets 27.00 Approved 27.00 0.00 0.00
55 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Any other transaction Job work charges Paid 100.00 Approved 28.30 0.00 0.00
56 Clean Science and Technology Limited Clean Fino-Chem Limited Wholly Owned Subsidiary Company Any other transaction Sale of solar units Captive consumption charge 106.70 Approved 106.70 0.00 0.00
57 Clean Fino-Chem Limited Mr. Keval Doshi Key Management Personnel (Non-Executive Director) Any other transaction Sitting fees 1.00 Approved 1.00 0.00 0.00
58 Clean Fino-Chem Limited Matrix Life Science Private Limited Entities in which KMP are interested Purchase of goods or services 100.00 Approved 37.50 0.00 11.00
Total value of transaction during the reporting period 8,546.60



Text Block

Textual Information(1) Mr. Ashok Ramnarayan Boob was a Managing Director of the Company till 31.03.2026. He Further Appointed as Whole-Time Director of the Company w.e.f. 01.04.2026.
Textual Information(2) Mr. Siddhartha Ashok Sikchi was a Whole-Time Director of the Company till 31.03.2026. He Further Appointed as Managing Director of the Company w.e.f. 01.04.2026
Textual Information(3) Prof. Ganapati Dadasaheb Yadav, has completed his term as a Non-Executive - Independent Director and consequently, ceased to be a Non-Executive - Independent Director with effect from 5th February, 2026.
Textual Information(4) Prof. Ganapati Dadasaheb Yadav, has completed his term as a Non-Executive - Independent Director and consequently, ceased to be a Non-Executive - Independent Director with effect from 5th February, 2026.
Textual Information(5) Ms. Madhu Dubhashi, has completed her term as a Non-Executive - Independent Director and consequently, ceased to be a Non-Executive - Independent Director with effect from 19th February, 2026.
Textual Information(6) Ms. Madhu Dubhashi, has completed her term as a Non-Executive - Independent Director and consequently, ceased to be a Non-Executive - Independent Director with effect from 19th February, 2026.